List of Precision BioSciences patents

Patents where

Current Assignee

Name

Precision BioSciences

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11274285 Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome	Patent 11274285 was granted and assigned to Precision BioSciences on March, 2022 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	11274285	March 15, 2022
‌ US Patent 11286291 Co-stimulatory domains for use in genetically-modified cells	Patent 11286291 was granted and assigned to Precision BioSciences on March, 2022 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	11286291	March 29, 2022
‌ US Patent 11278632 Engineered nucleases useful for treatment of hemophilia A	Patent 11278632 was granted and assigned to Precision BioSciences on March, 2022 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	11278632	March 22, 2022
‌ US Patent 10093900 Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene	Patent 10093900 was granted and assigned to Precision BioSciences on October, 2018 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	10093900	October 9, 2018
‌ US Patent 9889160 Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene	Patent 9889160 was granted and assigned to Precision BioSciences on February, 2018 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	9889160	February 13, 2018
‌ US Patent 10041053 Rationally-designed single-chain meganucleases with non-palindromic recognition sequences	Patent 10041053 was granted and assigned to Precision BioSciences on August, 2018 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	10041053	August 7, 2018
‌ US Patent 11384335 Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)	Patent 11384335 was granted and assigned to Precision BioSciences on July, 2022 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	11384335	July 12, 2022
‌ US Patent 9993502 Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene	Patent 9993502 was granted and assigned to Precision BioSciences on June, 2018 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	9993502	June 12, 2018
‌ US Patent 9950011 Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene	Patent 9950011 was granted and assigned to Precision BioSciences on April, 2018 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	9950011	April 24, 2018
‌ US Patent 9950010 Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene	Patent 9950010 was granted and assigned to Precision BioSciences on April, 2018 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	9950010	April 24, 2018
‌ US Patent 9969975 Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene	Patent 9969975 was granted and assigned to Precision BioSciences on May, 2018 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	9969975	May 15, 2018
‌ US Patent 9340777 Rationally-designed single-chain meganucleases with non-palindromic recognition sequences	Patent 9340777 was granted and assigned to Precision BioSciences on May, 2016 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	9340777	May 17, 2016
‌ US Patent 8445251 Rationally-designed single-chain meganucleases with non-palindromic recognition sequences	Patent 8445251 was granted and assigned to Precision BioSciences on May, 2013 by the United States Patent and Trademark Office.		Precision BioSciences	United States Patent and Trademark Office	8445251	May 21, 2013
‌ US Patent 9889161 Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene	Patent 9889161 was granted and assigned to Precision BioSciences on February, 2018 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	9889161	February 13, 2018
‌ US Patent 9993501 Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene	Patent 9993501 was granted and assigned to Precision BioSciences on June, 2018 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	9993501	June 12, 2018
‌ US Patent 10093899 Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene	Patent 10093899 was granted and assigned to Precision BioSciences on October, 2018 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	10093899	October 9, 2018
‌ US Patent 11266693 Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene	Patent 11266693 was granted and assigned to Precision BioSciences on March, 2022 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	11266693	March 8, 2022
‌ US Patent 11268065 Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene	Patent 11268065 was granted and assigned to Precision BioSciences on March, 2022 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	11268065	March 8, 2022
‌ US Patent 11053484 Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene	Patent 11053484 was granted and assigned to Precision BioSciences on July, 2021 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	11053484	July 6, 2021
‌ US Patent 9434931 Rationally-designed single-chain meganucleases with non-palindromic recognition sequences	Patent 9434931 was granted and assigned to Precision BioSciences on September, 2016 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	9434931	September 6, 2016
‌ US Patent 10799535 Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene	Patent 10799535 was granted and assigned to Precision BioSciences on October, 2020 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	10799535	October 13, 2020
‌ US Patent 9683257 Recognition sequences for I-CreI-derived meganucleases and uses thereof	Patent 9683257 was granted and assigned to Precision BioSciences on June, 2017 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	9683257	June 20, 2017
‌ US Patent 10800833 Co-stimulatory domains for use in genetically-modified cells	Patent 10800833 was granted and assigned to Precision BioSciences on October, 2020 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	10800833	October 13, 2020
‌ US Patent 11008548 Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)	Patent 11008548 was granted and assigned to Precision BioSciences on May, 2021 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	11008548	May 18, 2021
‌ US Patent 11186822 Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)	Patent 11186822 was granted and assigned to Precision BioSciences on November, 2021 by the United States Patent and Trademark Office.	Precision BioSciences	Precision BioSciences	United States Patent and Trademark Office	11186822	November 30, 2021

Results per page:

43 results

0 selected

43 results

0 selected